GKOS is currently developing the following drugs: Sham Procedure, Gen 2 Travoprost Intracameral Implant, Timolol Eye Drops 0.5%, Idose Tr 75 Μg In Conjunction With Cataract Surgery, Sham Procedure In Conjunction With Cataract Surgery, Travoprost Intraocular Implant, Sham Procedure 1, Istent Infinite, Sham Procedure 2. These drug candidates are in various stages of clinical development as the company works toward FDA approval.